Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02268253
Title Tagraxofusp (SL-401) in Patients With CMML or MF
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Stemline Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of California, Los Angeles Los Angeles California 90095 United States Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Norton Cancer Institute Louisville Kentucky 40207 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Weill Cornell Medical Center New York New York 10021 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Alberta Edmonton Alberta T6G 2G3 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field